NLVP

New Leaf Venture Partners Portfolio holdings

AUM $52.9M
This Quarter Return
+19.43%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$151M
AUM Growth
+$151M
Cap. Flow
-$5.49M
Cap. Flow %
-3.64%
Top 10 Hldgs %
95.41%
Holding
16
New
3
Increased
6
Reduced
2
Closed
2

Top Buys

1
DVAX icon
Dynavax Technologies
DVAX
$4.81M
2
ESPR icon
Esperion Therapeutics
ESPR
$4.07M
3
CMRX
Chimerix, Inc.
CMRX
$3.19M
4
XLRN
Acceleron Pharma Inc.
XLRN
$2.84M
5
DERM
Dermira, Inc.
DERM
$2.31M

Top Sells

1
RLYP
RELYPSA INC COM
RLYP
$19.8M
2
CALA
Calithera Biosciences, Inc
CALA
$3M
3
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$2.38M
4
SAGE
Sage Therapeutics
SAGE
$2.2M

Sector Composition

1 Healthcare 87.42%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALDR
1
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$34.8M 23.09%
657,783
+24,490
+4% +$1.3M
ARAV
2
DELISTED
Aravive, Inc. Common Stock
ARAV
$31M 20.57%
2,039,223
– –
OXFD
3
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$19.1M 12.64%
1,377,497
– –
CMRX
4
DELISTED
Chimerix, Inc.
CMRX
$14.8M 9.82%
320,608
+69,000
+27% +$3.19M
DVAX icon
5
Dynavax Technologies
DVAX
$1.16B
$14.3M 9.51%
612,498
+205,505
+50% +$4.81M
MRNS
6
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$7.58M 5.02%
653,494
+129,242
+25% +$1.5M
ACAD icon
7
Acadia Pharmaceuticals
ACAD
$4.33B
$7.42M 4.92%
177,230
+44,169
+33% +$1.85M
RLYP
8
DELISTED
RELYPSA INC COM
RLYP
$7.32M 4.85%
221,204
-598,629
-73% -$19.8M
ESPR icon
9
Esperion Therapeutics
ESPR
$468M
$4.07M 2.7%
+49,816
New +$4.07M
KPTI icon
10
Karyopharm Therapeutics
KPTI
$58.8M
$3.45M 2.28%
126,687
– –
XLRN
11
DELISTED
Acceleron Pharma Inc.
XLRN
$2.84M 1.88%
+89,738
New +$2.84M
DERM
12
DELISTED
Dermira, Inc.
DERM
$2.31M 1.53%
+131,590
New +$2.31M
CALA
13
DELISTED
Calithera Biosciences, Inc
CALA
$970K 0.64%
135,890
-420,146
-76% -$3M
AKAO
14
DELISTED
Achaogen, Inc.
AKAO
$800K 0.53%
132,728
+4,000
+3% +$24.1K
SAGE
15
DELISTED
Sage Therapeutics
SAGE
– –
-43,770
Closed -$2.2M
GEVA
16
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
– –
-24,379
Closed -$2.38M